Michael Boutros

Person

Heidelberg, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Cytotoxic T cell response modifiers
- Patent number 11,802,285
- Issue date Oct 31, 2023
- Deutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts
- Philipp Beckhove
- G01 - MEASURING TESTING
Information Patent Grant
Use of BUBR1 as a biomarker of drug response to furazanobenzimidazoles
- Patent number 10,222,377
- Issue date Mar 5, 2019
- Basilea Pharmaceutica AG
- Heidi Alexandra Lane
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Chromene derivatives and their analogs as Wnt pathway antagonists
- Patent number 10,065,939
- Issue date Sep 4, 2018
- Deutsches Krebsforschungszentrum
- Michael Boutros
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cytotoxic T cell response modifiers
- Patent number 9,994,854
- Issue date Jun 12, 2018
- Deutsches Krebsforschungszentrum
- Philipp Beckhove
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of BUBR1 as a biomarker of drug response to furazanobenzimidazoles
- Patent number 9,970,938
- Issue date May 15, 2018
- Basilea Pharmaceutica AG
- Heidi Alexandra Lane
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Chromene derivatives and their analoga as Wnt pathway antagonists
- Patent number 9,371,333
- Issue date Jun 21, 2016
- Deutsches Krebsforschungszentrum
- Michael Boutros
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Gpr177 as target and marker in tumors
- Patent number 9,062,114
- Issue date Jun 23, 2015
- Deutsches Krebsforschungszentrum
- Michael Boutros
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tricyclic pyrimidine derivatives as wnt antagonists
- Patent number 8,629,272
- Issue date Jan 14, 2014
- Deutsches Krebsforschungszentrum
- Florian Fuchs
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
INTRACELLULAR KINASE ASSOCIATED WITH RESISTANCE AGAINST T-CELL MEDI...
- Publication number 20230228760
- Publication date Jul 20, 2023
- iOmx Therapeutics AG
- Valentina VOLPIN
- G01 - MEASURING TESTING
Information Patent Application
INTRACELLULAR KINASE ASSOCIATED WITH RESISTANCE AGAINST ANTI-TUMOUR...
- Publication number 20210040486
- Publication date Feb 11, 2021
- iOmx Therapeutics AG
- Antonio SORRENTINO
- G01 - MEASURING TESTING
Information Patent Application
MODULATORS OF TUMOR IMMUNE RESISTANCE FOR THE TREATMENT OF CANCER
- Publication number 20200164068
- Publication date May 28, 2020
- Deutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts
- Nisit KHANDELWAL
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
OR10H1 ANTIGEN BINDING PROTEINS AND USES THEREOF
- Publication number 20200024347
- Publication date Jan 23, 2020
- iOmx Therapeutics AG
- Sebastian MEIER-EWERT
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CYTOTOXIC T CELL RESPONSE MODIFIERS
- Publication number 20200002706
- Publication date Jan 2, 2020
- Deutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts
- Philipp Beckhove
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
IMMUNE MODULATORS FOR REDUCING IMMUNE-RESISTANCE IN MELANOMA AND OT...
- Publication number 20190263906
- Publication date Aug 29, 2019
- Philipp Beckhove
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MODULATORS OF CCR9 FOR TREATING TUMOR RESISTANCE TO IMMUNE RESPONSES
- Publication number 20190054110
- Publication date Feb 21, 2019
- Deutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts
- Nisit KHANDELWAL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CHROMENE DERIVATIVES AND THEIR ANALOGS AS WNT PATHWAY ANTAGONISTS
- Publication number 20180334442
- Publication date Nov 22, 2018
- DEUTSCHES KREBSFORSCHUNGSZENTRUM
- Michael Boutros
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CYTOTOXIC T CELL RESPONSE MODIFIERS
- Publication number 20180298388
- Publication date Oct 18, 2018
- DEUTSCHES KREBSFORSCHUNGSZENTRUM
- Philipp Beckhove
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CHROMENE DERIVATIVES AND THEIR ANALOGS AS WNT PATHWAY ANTAGONISTS
- Publication number 20160355496
- Publication date Dec 8, 2016
- DEUTSCHES KREBSFORSCHUNGSZENTRUM
- Michael Boutros
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USE OF BUBR1 AS A BIOMARKER OF DRUG RESPONSE TO FURAZANOBENZIMIDAZOLES
- Publication number 20160320397
- Publication date Nov 3, 2016
- Basilea Pharmaceutica AG
- Heidi Alexandra Lane
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CYTOTOXIC T CELL RESPONSE MODIFIERS
- Publication number 20160201066
- Publication date Jul 14, 2016
- DEUTSCHES KREBSFORSCHUNGSZENTRUM
- Philipp Beckhove
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GPR177 AS TARGET AND MARKER IN TUMORS
- Publication number 20140227276
- Publication date Aug 14, 2014
- RUPRECHT-KARLS-UNIVERSITAET HEIDELBERG
- Michael Boutros
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
USE OF BUBR1 AS A BIOMARKER OF DRUG RESPONSE TO FURAZANOBENZIMIDAZOLES
- Publication number 20140045897
- Publication date Feb 13, 2014
- Heidi Alexandra Lane
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CHROMENE DERIVATIVES AND THEIR ANALOGA AS WNT PATHWAY ANTAGONISTS
- Publication number 20130303550
- Publication date Nov 14, 2013
- Ruprecht-Karls-Universitat Heidelberg
- Michael Boutros
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CHROMENE DERIVATIVES AND THEIR ANALOGA AS WNT PATHWAY ANTAGONISTS
- Publication number 20130296344
- Publication date Nov 7, 2013
- Ruprecht-Karls-Universitat Heidelberg
- Michael Boutros
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL MODULATORS OF TRAIL SIGNALLING
- Publication number 20130195884
- Publication date Aug 1, 2013
- DEUTSCHES KREBSFORSCHUNGSZENTRUM
- Michael Boutros
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TRICYCLIC PYRIMIDINE DERIVATIVES AS WNT ANTAGONISTS
- Publication number 20120157481
- Publication date Jun 21, 2012
- Deutsches Krebsforschungszentrum
- Florian Fuchs
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IDENTIFICATION OF JAK/STAT PATHWAY MODULATING GENES BY GENOME WIDE...
- Publication number 20090186815
- Publication date Jul 23, 2009
- Michael Boutros
- C07 - ORGANIC CHEMISTRY

Michael Boutros

Person

Patents Grantslast 30 patents

Cytotoxic T cell response modifiers

Use of BUBR1 as a biomarker of drug response to furazanobenzimidazoles

Chromene derivatives and their analogs as Wnt pathway antagonists

Cytotoxic T cell response modifiers

Use of BUBR1 as a biomarker of drug response to furazanobenzimidazoles

Chromene derivatives and their analoga as Wnt pathway antagonists

Gpr177 as target and marker in tumors

Tricyclic pyrimidine derivatives as wnt antagonists

Patents Applicationslast 30 patents

INTRACELLULAR KINASE ASSOCIATED WITH RESISTANCE AGAINST T-CELL MEDI...

INTRACELLULAR KINASE ASSOCIATED WITH RESISTANCE AGAINST ANTI-TUMOUR...

MODULATORS OF TUMOR IMMUNE RESISTANCE FOR THE TREATMENT OF CANCER

OR10H1 ANTIGEN BINDING PROTEINS AND USES THEREOF

CYTOTOXIC T CELL RESPONSE MODIFIERS

IMMUNE MODULATORS FOR REDUCING IMMUNE-RESISTANCE IN MELANOMA AND OT...

MODULATORS OF CCR9 FOR TREATING TUMOR RESISTANCE TO IMMUNE RESPONSES

CHROMENE DERIVATIVES AND THEIR ANALOGS AS WNT PATHWAY ANTAGONISTS

CYTOTOXIC T CELL RESPONSE MODIFIERS

CHROMENE DERIVATIVES AND THEIR ANALOGS AS WNT PATHWAY ANTAGONISTS

USE OF BUBR1 AS A BIOMARKER OF DRUG RESPONSE TO FURAZANOBENZIMIDAZOLES

CYTOTOXIC T CELL RESPONSE MODIFIERS

GPR177 AS TARGET AND MARKER IN TUMORS

USE OF BUBR1 AS A BIOMARKER OF DRUG RESPONSE TO FURAZANOBENZIMIDAZOLES

CHROMENE DERIVATIVES AND THEIR ANALOGA AS WNT PATHWAY ANTAGONISTS

CHROMENE DERIVATIVES AND THEIR ANALOGA AS WNT PATHWAY ANTAGONISTS

NOVEL MODULATORS OF TRAIL SIGNALLING

TRICYCLIC PYRIMIDINE DERIVATIVES AS WNT ANTAGONISTS

IDENTIFICATION OF JAK/STAT PATHWAY MODULATING GENES BY GENOME WIDE...